Login to Your Account

NicOx Shares Soar On Pfizer Deal For Ophthalmic Drugs

By Aaron Lorenzo

Wednesday, March 8, 2006
The French firm NicOx SA stands to break the bank, to the tune of up to nearly $400 million, per terms of a technology deal with Pfizer Inc. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription